VTGN:NASDAQ
Vistagen Therapeutics Inc
$0.67
arrow_downward
-2.87%(-0.020) 1D
$0.67
arrow_upward
+0.46% (+0.0031)bedtimeAfter hours
Closed: Jun 18, 4:00:00 PM GMT-4 · USD
search
All symbols
1D
5D
1M
6M
YTD
1Y
5Y
MAX
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for VTGN...
Open
$0.69
High
$0.73
Low
$0.67
Mkt. cap
27.50M
Avg. vol.
1.02M
Volume
1.09M
52-wk high
$5.14
52-wk low
$0.43
EPS
-$1.90
Beta
0.32
Shares outstanding
41.03M
No. of employees
59
Open
$0.69
High
$0.73
Low
$0.67
Mkt. cap
27.50M
Avg. vol.
1.02M
Volume
1.09M
52-wk high
$5.14
52-wk low
$0.43
EPS
-$1.90
Beta
0.32
Shares outstanding
41.03M
No. of employees
59
Analyst outlook
Analyst Ratings
Based on 1 analyst giving stock ratings to VTGN in the past 3 months
Hold
Buy
0
Hold
1
Sell
0
12 month forecast
Based on 1 Wall Street analyst offering 12 month price targets for VTGN in the last 3 months.
Highest
Current $0.67
Average
(-100.00%)
Lowest
(-100.00%)
News stories
From sources across the web
Stock Titan
·
3 days ago
Phase 3 data for Vistagen intranasal anxiety drug due this month
About Vistagen Therapeutics Inc
CEO-
Employees59
Founded1998
HeadquartersSouth San Francisco, California, United States
SectorBiotechnology
Websitevistagen.com
AI content may include mistakes. Learn more